Trial · NCT00878449
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Assess the safety profile of ABT-263 when administered in combination with etoposide/cisplatin in subjects with Cancer. | Weekly | |
| Primary | Characterize the pharmacokinetics of ABT-263 when administered in combination with etoposide/cisplatin . | Weekly | |
| Primary | Determine the maximum tolerable dose (MTD) of ABT-263 when administered in combination with etoposide/cisplatin. | Weekly | |
| Primary | Determine the recommended Phase 2 dose (RPTD) of ABT-263 when administered in combination with etoposide/cisplatin. | Weekly | |
| Secondary | Evaluate preliminary data regarding progression free survival (PFS). | Bi-monthly | |
| Secondary | Evaluate preliminary data regarding objective response rate (ORR). | Bi-monthly | |
| Secondary | Evaluate preliminary data regarding time to tumor progression (TTP). | Bi-monthly | |
| Secondary | Evaluate preliminary data regarding overall survival (OS). | Bi-monthly | |
| Secondary | Evaluate preliminary data regarding duration of overall response. | Bi-monthly | |
| Secondary | Evaluate preliminary data regarding Eastern Cooperative Oncology Group (ECOG) performance status. | Bi-monthly | |
| Secondary | Evaluate biomarkers | Bi-monthly | Define the relationship between disease state (related to patient selection and monitoring), B-Cell Lymphoma 2 (Bcl-2) family protein expression, and potential response to the proposed therapy ABT-263 and etoposide/cisplatin. |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00878449/registered